Hoeksel S A, Schreuder J J, Blom J A, Maessen J G, Penn O C
Department of Anaesthesiology, University of Limburg, Maastricht, The Netherlands.
Intensive Care Med. 1996 Jul;22(7):688-93. doi: 10.1007/BF01709748.
To evaluate the feasibility of closed-loop blood pressure control during cardiac surgery.
A closed-loop system regulated peroperative hypertension by controlling the infusion rate of the vasodilator nitroglycerin (NTG). The controller consisted of a regulator which was monitored by a supervisory computer program. Mean arterial pressure (MAP) was calculated every 5 s from measurements of the radial artery pressure signal. The regulator calculated an NTG infusion rate with each new MAP measurement. The supervisory computer program monitored the regulator's actions and adapted or overruled the regulator when required.
The cardiac surgery operating room.
46 patients who were scheduled for cardiac surgery and who developed peroperative hypertension.
Patients were scheduled for either bypass or valve replacement surgery. The closed-loop system was used to control hypertension before and after cardiopulmonary bypass. The use of the closed-loop system did not require deviation from the protocol normally used during cardiac surgery. All patients received standard continuous anaesthesia with opioids.
Initial automatic control was achieved in 9.4 (4.1 SD) min. The percentage of time that MAP remained in a range around the target MAP of +/- 10 and +/- 20 mmHg was 74 and 94%, respectively. The mean NTG infusion rate while MAP was within 5 mmHg of target MAP was 1.14 (0.84 SD) micrograms kg-1 min-1. Target MAP was set between 65 and 90 mmHg. There was a small group of patients (6 out of 46) who did not respond to NTG and required alternative drug therapy.
The controller provided fast and stable control in all patients. The expert knowledge implemented through the supervisory computer program enabled the controller to respond adequately to the rapid changes in arterial pressures commonly associated with cardiac surgery. We conclude that closed-loop control of arterial pressure is feasible not only in the cardiac surgical care unit but also during cardiac surgery.
评估心脏手术期间闭环血压控制的可行性。
一种闭环系统通过控制血管扩张剂硝酸甘油(NTG)的输注速率来调节术中高血压。该控制器由一个调节器组成,由一个监控计算机程序进行监测。平均动脉压(MAP)每5秒根据桡动脉压力信号测量值计算得出。调节器根据每次新的MAP测量值计算NTG输注速率。监控计算机程序监测调节器的动作,并在需要时调整或否决调节器。
心脏手术手术室。
46例计划进行心脏手术且术中出现高血压的患者。
患者计划进行搭桥或瓣膜置换手术。闭环系统用于体外循环前后控制高血压。使用闭环系统并不需要偏离心脏手术通常使用的方案。所有患者均接受标准的阿片类药物持续麻醉。
在9.4(4.1标准差)分钟内实现了初始自动控制。MAP保持在目标MAP±10和±20 mmHg范围内的时间百分比分别为74%和94%。MAP在目标MAP的5 mmHg范围内时,NTG的平均输注速率为1.14(0.84标准差)微克·千克⁻¹·分钟⁻¹。目标MAP设定在65至90 mmHg之间。有一小部分患者(46例中的6例)对NTG无反应,需要替代药物治疗。
该控制器在所有患者中提供了快速稳定的控制。通过监控计算机程序实施的专业知识使控制器能够充分应对心脏手术中常见的动脉压力快速变化。我们得出结论,动脉压的闭环控制不仅在心脏外科护理单元可行,在心脏手术期间也可行。